[ad_1]
(AOF) – Onward Medical announces that its shares will be listed on Euronext Paris from Tuesday, September 24, in addition to its current listings on Euronext Brussels and Amsterdam. This medtech company, which is behind innovative therapies to restore movement, function and independence in people with spinal cord injuries (SCI), specifies that this listing “does not give rise to the creation of new shares and therefore has no dilutive effect for current shareholders”.
On September 19, 2024, Onward announced that the newest study participant had been implanted with the ARC-BCI System to restore mobility after spinal cord injury (SCI). The system was implanted on September 12, 2024 by Dr. Jocelyne Bloch, Head of Functional Neurosurgery at the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland.
“We are pleased to facilitate trading in Onward Medical’s securities by making them available on Euronext Paris,” said Dave Marver, CEO of the company. “This listing provides greater access to French investors, supporting our efforts to address the significant unmet needs of people with spinal cord injuries in France and around the world.”
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from sources it considers the most reliable. However, the reader remains solely responsible for their interpretation and the use of the information made available to him. Thus, the reader must hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article? Share it with your friends using the buttons below.
[ad_2]
Source link -85